SGLT2 Inhibitor Initiation Linked to Lower Kidney Disease Risk in Gout
A multicenter retrospective cohort study indicates that initiating sodium-glucose cotransporter-2 inhibitors is associated with lower risks of incident chronic kidney ...
A multicenter retrospective cohort study indicates that initiating sodium-glucose cotransporter-2 inhibitors is associated with lower risks of incident chronic kidney ...
A cross-sectional study reveals that kidney function disparities between pretransplant and post-transplant diabetes in solid-organ recipients reflect differing clinical selection ...
A ten-year health economic budget impact simulation demonstrates that integrating PromarkerD biomarker testing into routine type 2 diabetes care could ...
A lifetime state-transition cohort model estimates that optimizing guideline-directed cardiovascular therapy and sodium-glucose cotransporter-2 inhibitors for adults with chronic kidney ...
Adults with type 2 diabetes who began SGLT2 inhibitor therapy achieved significant glycemic control and weight reduction without showing a ...
A cross-sectional study of 6,578 Singapore heart failure patients found quadruple drug therapy prescriptions increased to 14.5 percent by 2022, ...
A systematic review of five randomized trials found SGLT2 inhibitors showed no overall superiority over metformin in women with polycystic ...
A narrative review evaluates renal replacement therapy for refractory diabetic ketoacidosis, proposing a standardized definition while distinguishing persistent acidaemia from ...
A retrospective study in Japan found that embedding an electronic pharmacist-led checklist into medical records was associated with higher discharge ...
A 30-year-old man with type 2 diabetes was successfully managed for emphysematous pyelonephritis through emergency antibiotic therapy, hemodialysis, and the ...
In a preclinical model of chronic pressure overload, eight weeks of empagliflozin treatment significantly reduced mortality, attenuated ventricular remodeling, and ...
A retrospective cohort study found that chronic kidney disease patients experiencing an initial eGFR dip greater than 10 percent had ...
A retrospective cohort study found that concomitant SGLT2 inhibitor use was associated with a significantly lower incidence of grade 2 ...
In the randomized PROVE trial, empagliflozin significantly reduced functional tricuspid regurgitation severity in heart failure patients with preserved ejection fraction ...
A comprehensive review in Frontiers in Cell and Developmental Biology outlines the shift of Alport syndrome from a histopathological entity ...
A nationwide case-series study reveals that ketoacidosis associated with sodium-glucose cotransporter 2 inhibitors presents heterogeneously, with older adults frequently experiencing ...
A narrative review synthesizes clinical and mechanistic evidence on endothelin receptor antagonists, highlighting their renal benefits alongside fluid retention risks ...
A large propensity-matched cohort study shows that SGLT2 inhibitor therapy increases diagnostic coding for polycythemia vera without raising confirmed rates ...
An updated narrative review outlines the chloride theory of heart failure, linking serum chloride dynamics to fluid redistribution, neurohormonal activation, ...
A scientific review details the molecular mechanisms connecting metabolic dysfunction to cardiorenal injury in cardiovascular–kidney–metabolic syndrome and outlines the multiorgan ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.